ArticleCancers2023

Characterisation of Aberrant Metabolic Pathways in Hepatoblastoma Using Liquid Chromatography and Tandem Mass Spectrometry (LC-MS/MS).

Alison Whitby et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.